END-STAGE RENAL DISEASE

Course overview

MORE THAN 500,000 PEOPLE IN THE UNITED STATES LIVE WITH END-STAGE RENAL DISEASE (ESRD). THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE (CKD) AND ITS PROGRESSION TO THIS TERMINAL DISEASE REMAINS A SIGNIFICANT SOURCE OF REDUCED QUALITY OF LIFE AND SIGNIFICANT PREMATURE MORTALITY. THE KIDNEY DISEASE IMPROVING GLOBAL OUTCOMES (KDIGO) DEFINE CKD USING MARKERS OF KIDNEY DAMAGE, SPECIFICALLY MARKERS THAT DETERMINE PROTEINURIA AND GLOMERULAR FILTRATION RATE. THIS ACTIVITY EXPLAINS WHEN THIS CONDITION SHOULD BE CONSIDERED ON THE DIFFERENTIAL DIAGNOSIS, ARTICULATES HOW TO PROPERLY EVALUATE FOR THIS CONDITION, AND HIGHLIGHTS THE INTERPROFESSIONAL TEAM'S ROLE IN CARING FOR PATIENTS WITH THIS CONDITION.